CS235303B2 - Method of ergopeptone production - Google Patents

Method of ergopeptone production Download PDF

Info

Publication number
CS235303B2
CS235303B2 CS825871A CS587182A CS235303B2 CS 235303 B2 CS235303 B2 CS 235303B2 CS 825871 A CS825871 A CS 825871A CS 587182 A CS587182 A CS 587182A CS 235303 B2 CS235303 B2 CS 235303B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
compounds
acid
compound
solution
Prior art date
Application number
CS825871A
Other languages
Czech (cs)
English (en)
Inventor
Hans Kobel
Jean-Jacques Sanglier
Hans Tscherter
Georg Bolliger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CS235303B2 publication Critical patent/CS235303B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
CS825871A 1981-08-07 1982-08-06 Method of ergopeptone production CS235303B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH5104/81A CH649300A5 (de) 1981-08-07 1981-08-07 Ergopeptinderivate, ihre herstellung und verwendung.

Publications (1)

Publication Number Publication Date
CS235303B2 true CS235303B2 (en) 1985-05-15

Family

ID=4287999

Family Applications (1)

Application Number Title Priority Date Filing Date
CS825871A CS235303B2 (en) 1981-08-07 1982-08-06 Method of ergopeptone production

Country Status (27)

Country Link
US (3) US4542135A (fi)
JP (1) JPS5843982A (fi)
AT (1) AT382156B (fi)
AU (1) AU558414B2 (fi)
BE (1) BE894046A (fi)
CA (1) CA1191802A (fi)
CH (1) CH649300A5 (fi)
CS (1) CS235303B2 (fi)
DD (2) DD211582A5 (fi)
DE (1) DE3228230A1 (fi)
DK (1) DK352082A (fi)
ES (2) ES8402348A1 (fi)
FI (1) FI72979C (fi)
FR (1) FR2511003B1 (fi)
GB (1) GB2109795B (fi)
GR (1) GR77262B (fi)
HU (2) HU190405B (fi)
IE (1) IE53647B1 (fi)
IL (1) IL66471A (fi)
IT (1) IT1152489B (fi)
MY (1) MY8600311A (fi)
NL (1) NL8203067A (fi)
NZ (1) NZ201504A (fi)
PH (1) PH22998A (fi)
PT (1) PT75384B (fi)
SE (1) SE452011B (fi)
ZA (1) ZA825727B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
JPS60104129A (ja) * 1983-11-11 1985-06-08 Hitachi Ltd フッ素含有ポリアミド酸誘導体及びポリイミドの製造方法
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
HU193317B (en) * 1985-06-12 1987-09-28 Richter Gedeon Vegyeszet Process for producing 2-bromo-alpha-ergochristin
CA2125288C (en) * 1992-12-24 2004-11-23 Sergio Mantegani Serotoninergic ergoline derivatives
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
US20070022720A1 (en) * 2005-07-27 2007-02-01 The Toro Company Cleaner for cooling system screen of outdoor power equipment unit
SG181896A1 (en) * 2009-12-23 2012-07-30 Map Pharmaceuticals Inc Novel ergoline analogs
US8604035B2 (en) 2011-06-23 2013-12-10 Map Pharmaceuticals, Inc. Fluoroergoline analogs
SG11201403434YA (en) 2011-12-19 2014-09-26 Map Pharmaceuticals Inc Novel iso-ergoline derivatives
EP2793583A4 (en) 2011-12-21 2015-08-12 Map Pharmaceuticals Inc NOVEL NEUROMODULATORY CONNECTIONS
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
CZ304709B6 (cs) * 2013-07-25 2014-09-03 Teva Czech Industries S.R.O. Izolovaný kmen houby Claviceps purpurea (Fr.) Tul., CCM 8404
CN113308442B (zh) * 2021-04-28 2023-06-27 天津大学 重组酿酒酵母菌株及其构建方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314959A (en) * 1961-05-10 1967-04-18 Sandoz Ltd Intermediates for the synthesis of ergot alkaloids
FR2292M (fr) * 1962-06-27 1964-01-27 Sandoz Sa Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine.
CH602765A5 (fi) * 1974-09-27 1978-07-31 Sandoz Ag
CH602766A5 (en) * 1974-09-27 1978-07-31 Sandoz Ag 10-Alpha-methoxy-di:hydro-beta-ergosine derivs.
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
CH626373A5 (fi) * 1977-02-22 1981-11-13 Sandoz Ag
GB1584464A (en) * 1977-04-19 1981-02-11 Farmaceutici Italia Ergot alkaloids
DE2717953A1 (de) * 1977-04-22 1978-10-26 Sandoz Ag Neue therapeutische mischung und verfahren zu deren herstellung
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
CH636011A5 (en) * 1978-01-01 1983-05-13 Sandoz Ag Administration forms for organic compounds
DE2962303D1 (en) * 1978-01-20 1982-04-29 Sandoz Ag Derivatives of ergopeptide alkaloids, process for their preparation and pharmaceutical compositions containing them
DE2803543A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Ergopeptidalkaloidderivate, ihre verwendung und herstellung
YU40046B (en) * 1978-09-04 1985-06-30 Lek Tovarna Farmacevtskih Process for preparing 2-bromo-9,10-dihydroergosine
US4609731A (en) * 1979-10-10 1986-09-02 Sandoz Ltd. Process for brominating ergot alkaloids
DD200571A1 (de) * 1981-07-22 1983-05-18 Alfred Baumert Verfahren zur herstellung von ergopeptinen mit modifiziertem prolinteil
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.

Also Published As

Publication number Publication date
FI72979C (fi) 1987-08-10
NL8203067A (nl) 1983-03-01
NZ201504A (en) 1986-08-08
JPH0437836B2 (fi) 1992-06-22
SE8204585L (sv) 1983-02-08
DE3228230A1 (de) 1983-02-17
DK352082A (da) 1983-02-08
MY8600311A (en) 1986-12-31
ATA302682A (de) 1986-06-15
IT8222768A0 (it) 1982-08-06
FI822670A0 (fi) 1982-07-30
SE8204585D0 (sv) 1982-08-05
IE821906L (en) 1983-02-07
FR2511003B1 (fr) 1986-12-05
GB2109795A (en) 1983-06-08
US4542135A (en) 1985-09-17
DD211582A5 (de) 1984-07-18
ZA825727B (en) 1984-03-28
AU558414B2 (en) 1987-01-29
ES8504825A1 (es) 1985-04-16
SE452011B (sv) 1987-11-09
US4681880A (en) 1987-07-21
FI822670L (fi) 1983-02-08
ES514766A0 (es) 1984-01-16
BE894046A (fr) 1983-02-07
ES526119A0 (es) 1985-04-16
IL66471A0 (en) 1982-12-31
ES8402348A1 (es) 1984-01-16
CA1191802A (en) 1985-08-13
FR2511003A1 (fr) 1983-02-11
IE53647B1 (en) 1989-01-04
DD206379A5 (de) 1984-01-25
IT1152489B (it) 1986-12-31
PH22998A (en) 1989-02-24
AU8678582A (en) 1983-03-03
HU190405B (en) 1986-09-29
JPS5843982A (ja) 1983-03-14
HUT37960A (en) 1986-03-28
AT382156B (de) 1987-01-26
IL66471A (en) 1986-02-28
FI72979B (fi) 1987-04-30
PT75384A (en) 1982-09-01
US4804660A (en) 1989-02-14
PT75384B (en) 1985-06-28
HU193373B (en) 1987-09-28
GR77262B (fi) 1984-09-11
GB2109795B (en) 1985-07-03
CH649300A5 (de) 1985-05-15

Similar Documents

Publication Publication Date Title
CS235303B2 (en) Method of ergopeptone production
US7534796B2 (en) Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
EP2895174B1 (en) Prodrugs of amino quinazoline kinase inhibitor
US5763454A (en) Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
KR20090116716A (ko) 칸나비노이드-ｃｂ1 길항작용과 아세틸콜린에스테라제 억제가 조합된 화합물
WO2023049518A1 (en) Benzimidazole carboxylic acids as glp-1r agonists
US6800623B2 (en) Method of treating schizophrenia
US3086972A (en) Aza-thiaxanthene derivatives
JPH0114235B2 (fi)
CS236782B2 (en) Processing of 5 s-(2r-butyl)peptidergotalkaloid
US5183816A (en) Bicyclic sulfur-containing compounds
EP1631552B1 (de) Verfahren zur synthese heterocyclischer verbindungen aus thioharnstoffderivaten
KR920001673B1 (ko) 피리미도이소퀴놀린 유도체의 제조방법
TW202146402A (zh) 幷環化合物及其製備方法、藥物組合物和應用
US5256655A (en) Bicyclic sulfur-containing compounds
CS199258B2 (en) Process for preparing new antibiotic compounds of rifamycine-s,substituted in 3 position by aliphatic substituted aminogroup
KR101919189B1 (ko) 다중치환 4H-티아졸로[4,5-e][1,4]다이아제핀-5,8-다이온 유도체 및 이의 용도
CZ55298A3 (cs) Proléčivo trovafloxacinu, způsoby jeho výroby a farmaceutické prostředky na jeho bázi
CA3231451A1 (en) Sstr4 agonist salts
EP0076622A1 (en) Anthelmintics
CS221924B2 (cs) Způsob výroby ergopeptinových derivátů
CS221926B2 (cs) Způsob výroby ergopeptinových derivátů
JPS5872593A (ja) 駆虫剤、その製法およびそれを含む医薬もしくは獣医薬組成物
SK342010A3 (sk) New addition salts of sitagliptin and preparations containing them
CS268684B2 (en) Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production